DNMT3A and myeloid neoplasm: DNMT3A is one DNA methyltransferase needed for de novo methylation throughout the genome: according to reports, 8–22% of myeloid neoplasms and 33% of PTCLs have DNMT3A mutations, which mostly affect the enzyme’s catalytic function [44].